亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

海南滿方園醫藥化工有限公司  

研發化學藥品 醫藥原料 中間體 化工原料

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:吳伯炯
  • 電話:0898-66518050
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 7-(4-氯丁氧基)-2(1H)-喹啉酮
7-(4-氯丁氧基)-2(1H)-喹啉酮
單價 面議對比
詢價 暫無
發貨 海南海口市付款后3天內
品牌 7-(4-氯丁氧基)-2(1H)-喹啉酮913613-82-8
過期 長期有效
更新 2022-03-15 09:14
 
詳細信息

英文名稱:2(1H)-Quinolinone,7-(4-chlorobutoxy)-英文同義詞:IpiprazoleImpurity7;7-(4-chlorobutoxy)-2(1H)-Quinolinone;7-(4-Chlorobutoxy)quinolin-2(1H)-one;7-(4-Chlorobutoxy)-1H-quinolin-2-one;2(1H)-Quinolinone,7-(4-chlorobutoxyChemicalbook)-;2-(2-carboxy-4-nitrophenyl)-5-nitrobenzoicacid中文名稱:7-(4-氯丁氧基)-2(1H)-喹啉酮中文同義詞:溴乙哌唑雜質26;依匹哌唑中間體1;7-氯丁氧基喹諾酮;7-(4-氯丁氧基)-2(1H)-喹啉酮;7-(4-氯丁基)-2-(1H)-喹啉酮;7-(4-氯丁氧基)-1H-喹啉-2-酮CBNumber:CB51872168分子式:C13H14ClNO2分子量:0MOLFile:913613-82-8.mol

©2025 海南滿方園醫藥化工有限公司 版權所有   技術支持:化工網   訪問量:16712  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |